Neoadjuvant lapatinib with trastuzumab for HER2-positive breast cancer
Dr Paolo Nuciforo - Vall d'Hebron Institute of Oncology, Barcelona, Spain
Neoadjuvant lapatinib with trastuzumab for HER2-positive breast cancer ( Dr Paolo Nuciforo - Vall d'Hebron Institute of Oncology, Barcelona, Spain )
6 Oct 2020
Actionable pathogenic variant detection in breast cancer genes
Prof Gareth Evans - The Central Manchester NHS Foundation Trust, Manchester, UK
Actionable pathogenic variant detection in breast cancer genes ( Prof Gareth Evans - The Central Manchester NHS Foundation Trust, Manchester, UK )
6 Oct 2020
OncoAlert and ecancer weekly roundup for September 27 - October 4th, 2020
Dr Gil Morgan - Skåne University Hospital in Lund, Sweden
OncoAlert and ecancer weekly roundup for September 27 - October 4th, 2020 ( Dr Gil Morgan - Skåne University Hospital in Lund, Sweden )
6 Oct 2020
Prediction of hot flushes in women taking tamoxifen for breast cancer prevention
Michael Hale - Queen Mary University, London, UK
Prediction of hot flushes in women taking tamoxifen for breast cancer prevention ( Michael Hale - Queen Mary University, London, UK )
5 Oct 2020
The impact of COVID-19 on breast cancer screening, treatment, research and meeti...
Prof David Cameron - Representative EBC Council
The impact of COVID-19 on breast cancer screening, treatment, research and meetings ( Prof David Cameron - Representative EBC Council )
5 Oct 2020
Improved decision making for older women with early breast cancer
Prof Lynda Wyld - University of Sheffield, Sheffield, UK
Improved decision making for older women with early breast cancer ( Prof	Lynda Wyld - University of Sheffield, Sheffield, UK )
2 Oct 2020
MINDACT: 70-gene signature test as guidance for breast cancer treatment
Josephine Lopes Cardozo - Netherlands Cancer Institute, Amsterdam, The Netherlan...
MINDACT: 70-gene signature test as guidance for breast cancer treatment ( Josephine Lopes Cardozo - Netherlands Cancer Institute, Amsterdam, The Netherlands )
1 Oct 2020
OS results from SOLAR-1: Alpelisib plus fulvestrant for HR positive, HER2 negati...
Prof Fabrice André - Institut Gustave Roussy, Paris, France
OS results from SOLAR-1: Alpelisib plus fulvestrant for HR positive, HER2 negative advanced breast cancer ( Prof Fabrice André - Institut Gustave Roussy, Paris, France )
29 Sep 2020
OncoAlert and ecancer weekly roundup for September 20 - 26, 2020
Dr Gil Morgan - Skåne University Hospital in Lund, Sweden
OncoAlert and ecancer weekly roundup for September 20 - 26, 2020 ( Dr Gil Morgan - Skåne University Hospital in Lund, Sweden )
28 Sep 2020
Highlights from ESMO 2020
Dr Bishal Gyawali - Queen's University, Kingston, Canada
Highlights from ESMO 2020 ( Dr Bishal Gyawali - Queen's University, Kingston, Canada )
25 Sep 2020
ASCENT: Sacituzumab govitecan vs treatment of physician’s choice in patients wit...
Dr Aditya Bardia - Massachusetts General Hospital, Boston, USA
ASCENT: Sacituzumab govitecan vs treatment of physician’s choice in patients with previously treated mTNBC ( Dr Aditya Bardia - Massachusetts General Hospital, Boston, USA )
23 Sep 2020
Breast cancer roundup from ESMO 2020
Dr Matteo Lambertini - San Martino Hospital, Genoa, Italy
Breast cancer roundup from ESMO 2020 ( Dr Matteo Lambertini - San Martino Hospital, Genoa, Italy )
23 Sep 2020